Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

LAMAs were largely prescribed for patients in Turkey who had uncontrolled asthma, older age, obesity, exacerbations, and/or worse lung function.

fluticasone propionate and short-acting beta agonist (SABA) albuterol sulfate. The drug – delivered using a proprietary Teva inhaler – could become the first ICS/SABA for both the adult and ...

The Salford study recruited a total of 4,233 patients who were taking inhaled corticosteroid (ICS) with or without a long acting beta 2-agonist (LABA ... has dropped the list of the next 15 ...

Here is the list of combination asthma inhalers currently licensed ... Table 9. Combination ICS + LABA inhalers with equivalent dosing. In: Asthma. Ann Arbor (MI): Michigan Medicine University of ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

This analysis spanned from 2016 to 2022. Nearly 50% of patients were initially prescribed LABA/inhaled corticosteroids. BOSTON — Compared with 17,800 patients starting new inhaled COPD ...

Other AbbVie drugs, including its once-best-selling multiuse medication Humira, have been targeted by new provisions in the ...

For patients with asthma that is not controlled on low-dose inhaled corticosteroids (ICs), guidelines recommend doubling the IC dose or adding a long-acting β-agonist (LABA). Inhaled ...